Caption Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Caption Management’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-19,826	Closed	-$809K	–	1221
2023 Q1	$766K	Sell	19,826 -5,174	-21%	-$213K	0.01%	688
2022 Q4	$1.11M	Buy	+25,000	New	+$1.05M	0.02%	717
2022 Q3	–	Sell	-3,900	Closed	-$218K	–	1630
2022 Q2	$218K	Sell	3,900 -2,100	-35%	-$125K	﹤0.01%	1222
2022 Q1	$373K	Sell	6,000 -24,000	-80%	-$1.47M	﹤0.01%	1188
2021 Q4	$1.65M	Buy	+30,000	New	+$1.57M	0.02%	855
2021 Q3	–	Sell	-56,800	Closed	-$3.37M	–	1611
2021 Q2	$3.91M	Sell	56,800 -14,767	-21%	-$1.13M	0.05%	437
2021 Q1	$5.52M	Buy	71,567 +43,067	+151%	+$3.97M	0.12%	225
2020 Q4	$2.82M	Buy	+28,500	New	+$3.49M	0.06%	357

Other funds holding LKFT

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Caption Management's LKFT Position: Q2 2023 in Review

Caption Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2023, closing a stake of 19,826 shares — an estimated $809K sold.

Caption Management first reported a position in LKFT in Q4 2020 and held it in 8 quarters. The position peaked at $5.52M in Q1 2021. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2023.

Caption Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Caption Management sold 19,826 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2023, an estimated $809K.
Caption Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2020 and held it in 8 quarters.
Caption Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $5.52M in Q1 2021.
76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2023.

Based on Caption Management's 13F filing for Q2 2023, filed 14 Aug 2023.